Kaiser Permanente is a California-based integrated HMO that operates under the Knox-Keene Health Care Service Plan Act on its California products — Cal. Health & Safety Code § 1340 et seq. Most California members are on a fully-insured Knox-Keene licensee plan; outside California, Kaiser operates in eight states (CA, CO, GA, HI, MD, OR, VA, WA) under both fully-insured and self-funded ERISA plan structures. The published Member Grievance & Appeals line at 1-800-464-4000 is Kaiser's national routing number, and the regional appeals offices (Northern California, Southern California, Northwest, Washington, Colorado) handle the actual casework — the appeal packet is addressed to the regional office that owns the enrollee's home zip code.
Kaiser appeals almost always go through the enrollee's treating physician — direct member-to-Kaiser routing is the exception rather than the rule. The treating physician forwards the appeal packet to the regional appeals team, and the kp.org secure-message inbox is the published surface for that forwarding. The ERISA § 503 procedure at 29 C.F.R. § 2560.503-1 still applies to self-funded Kaiser employer plans, and California's Knox-Keene / DMHC framework under Cal. Health & Safety Code § 1368 still applies to fully-insured CA products — the letter cites both the carrier-published appeals framework and the underlying federal / state framework. For ACA marketplace plans, the four-month external-review channel under 45 C.F.R. § 147.136(d) attaches at the second-stage level.
The EOB reason codes a Kaiser denial typically carries are 'no referral on file' for specialty referrals that didn't go through the PCP-routing first, 'step-therapy criteria not satisfied' for pharmacy denials, and 'out-of-network specialist referral' for second-opinion or specialty referrals that didn't route through Kaiser's network. A well-built Kaiser appeal letter cites the regional appeals office, attaches the treating-physician's clinical record, frames the procedural defect (referral routing, step-therapy adjunct, or specialist routing) as the eligible waiver basis, and reserves the four-month external-review window under 45 C.F.R. § 147.136(d) where the plan is an ACA marketplace product, or the ERISA civil-action remedy at 29 U.S.C. § 1132(a)(1)(B) where the plan is a self-funded employer plan.